AskBio Contribution to Advancing Gene Therapy Highlighted at ESGCT 30th Congress ...Middle East

PR Newswire - News
AskBio Contribution to Advancing Gene Therapy Highlighted at ESGCT 30th Congress
2023 congress represents company's most extensive ESGCT presence to date Includes data from AskBio Wholly Owned Manufacturing Subsidiaries, TAAV and Viralgen RESEARCH TRIANGLE PARK, N.C., Oct. 23, 2023 /PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and...

Hence then, the article about askbio contribution to advancing gene therapy highlighted at esgct 30th congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AskBio Contribution to Advancing Gene Therapy Highlighted at ESGCT 30th Congress )

Apple Storegoogle play

Last updated :

Also on site :



Latest News